RPM With No Wearable: Monitor Patients Without Gadgets

Every health system that has run a remote patient monitoring program knows the same quiet failure mode. The devices ship, patients enroll, and within a few weeks the data feed thins out. Cuffs sit in drawers. Wristbands stop charging. The dashboard that was supposed to catch deterioration early goes dark on exactly the patients who need it most. This is the core argument for RPM no wearable: monitoring that depends on a patient remembering to wear, charge, sync, or operate hardware inherits the failure rate of that hardware. A program that asks for nothing physical removes the single largest source of attrition before it starts.

"Patient adherence is a top concern for nearly 70% of organizations deploying remote monitoring technologies, with cumbersome devices, complex protocols, and gradual loss of motivation cited as the leading causes of dropoff." - Medical Product Outsourcing, 2024 RPM trends report

What RPM no wearable actually means

The phrase RPM no wearable describes a category of patient monitoring without wearables in which vital signs are captured through a sensor the patient already owns and already uses: the camera on a smartphone, tablet, or laptop. The underlying method is remote photoplethysmography, usually shortened to rPPG. When light hits skin, blood volume changes with each heartbeat alter how much light the skin reflects. These changes are invisible to the human eye but measurable by a standard camera. From a short recording of a patient's face, an rPPG pipeline can estimate heart rate, respiratory rate, and related cardiovascular signals without anything touching the body.

This matters because the bottleneck in most programs was never the algorithm. It was the device. No-device remote monitoring shifts the burden from the patient to software. The patient looks at a screen for roughly a minute during a daily check-in. There is no cuff to inflate, no finger clip to position, no battery to manage, and no Bluetooth pairing to troubleshoot with a call-center nurse.

For care-at-home program directors, the operational implication is direct. The reasons patients drop out of wearable-free RPM are different from, and far fewer than, the reasons they abandon hardware. You are no longer fighting charging cycles, lost equipment, or the cognitive load of an unfamiliar gadget.

How wearable-free RPM compares to device-based programs

The trade-offs are real and worth laying out plainly. Camera-based monitoring is not a drop-in replacement for continuous telemetry in an ICU. It is a strong fit for population-scale post-discharge and chronic-care monitoring where adherence, not millisecond resolution, is the binding constraint.

| Dimension | Wearable / device-based RPM | RPM no wearable (camera-based) | |---|---|---| | Patient hardware required | Cuff, oximeter, wristband, or patch | None beyond a phone or tablet | | Setup friction | Pairing, charging, calibration | Open app, look at camera | | Common dropoff cause | Lost device, dead battery, fatigue | Daily-habit lapse only | | Logistics cost | Shipping, returns, replacement, sanitizing | Software distribution | | Measurement mode | Often continuous or on-demand | Spot check during check-in | | Equity / access | Limited by device supply | Scales with existing smartphones | | Best clinical fit | Acute, continuous telemetry needs | Post-discharge, chronic, hospital-at-home |

A few patterns stand out from how programs actually perform in the field:

• Device logistics are a hidden line item. Shipping, tracking, sanitizing, and replacing lost hardware consumes staff time that rarely appears in the original business case.
• Attrition is front-loaded. Most patients who abandon a device do so in the first two to three weeks, which is also the highest-risk window for readmission.
• Equity widens or narrows with the hardware model. A 2024 analysis of underserved communities found wearable utilization at just 14 percent, while smartphone ownership in the same populations runs far higher.
• Camera-based capture removes the return step entirely. Nothing has to come back, which eliminates an entire reverse-logistics workflow.

Industry Applications

Hospital-at-Home Programs

Acute hospital-at-home models depend on frequent vital-sign capture to justify treating patients outside the ward. The friction of teaching an acutely ill patient or an overwhelmed family caregiver to operate multiple devices is significant. Patient monitoring without wearables lowers that onboarding barrier to a single screen interaction, which makes daily structured check-ins realistic even for older or less tech-fluent patients.

Post-discharge and readmission reduction

The 30 days after discharge are where penalties and avoidable returns concentrate. A wearable-free RPM check-in that takes a minute is far more likely to be completed daily than a multi-step device routine. Higher completion rates mean a denser trend line, and a denser trend line is what lets a care team see a resting heart rate creep up before a patient feels unwell.

Chronic disease and population health

For population health VPs managing thousands of patients with heart failure, COPD, or hypertension, per-patient device cost and logistics cap how many people a program can cover. Removing hardware changes the unit economics. The marginal cost of adding a patient to no-device remote monitoring is closer to a software license than a hardware deployment, which is what makes true population scale feasible.

Virtual nursing and centralized monitoring

Centralized virtual nursing teams watch large panels from a single command center. Standardized camera-based capture produces consistent, comparable readings across an entire panel, rather than a patchwork of different device brands and data formats that each require separate integration work.

Current research and evidence

The accuracy literature for camera-based vital signs has matured quickly. A 2023 validation of smartphone rPPG reported strong agreement with reference devices for heart rate (roughly 97 percent accuracy), systolic and diastolic blood pressure (around 93 percent), and respiratory rate (about 84 percent) in normotensive adults. Separate clinical work in cardiovascular disease patients found pulse-rate agreement with a mean absolute error near 1.06 beats per minute, and some published rPPG frameworks have reported heart-rate mean absolute error below 2 bpm and SpO2 error under 2 percent on public datasets.

The research is equally clear about limits. A 2024 study reported that rPPG accuracy for heart rate drops sharply at elevated heart rates, while low lighting had comparatively little effect. Motion, lack of automatic face tracking, and variation across skin tones remain active engineering challenges. Responsible programs treat camera-based readings as trend and triage signals during structured check-ins, not as continuous arrhythmia surveillance, and they build escalation pathways for confirmatory measurement when a reading falls outside expected ranges.

The adherence evidence is the other half of the case. Even a perfectly accurate device produces no data when it sits unused. A 2024 pilot in older adults found median daily wear-time adherence of 92 percent, but nearly a third of participants wore the device fewer than four days across a two-week window. That gap between best-case and typical adherence is precisely what wearable-free RPM is designed to close.

The future of RPM no wearable

Three trends point toward broader adoption. First, model robustness is improving, with research explicitly targeting performance at high heart rates, poor lighting, and across diverse skin tones, which directly addresses today's accuracy gaps. Second, reimbursement and care-model momentum favor scalable, low-friction monitoring as hospital-at-home and value-based arrangements expand. Third, the economics are hard to ignore: the US RPM market was valued near 14.2 billion dollars in 2024 with projections toward 29 billion by 2030, and the programs that scale within that growth will be the ones that solve adherence rather than ship more hardware.

The likely end state is not camera-only or device-only but tiered. Camera-based capture handles the high-volume, lower-acuity majority, while targeted devices are reserved for the smaller cohort that genuinely needs continuous telemetry. The strategic question for a CMO is no longer whether wearable-free monitoring works, but which patients it can cover so that scarce hardware and nursing attention concentrate where they matter most.

Frequently asked questions

Can you really monitor a patient with no wearable at all?

Yes, for spot-check vital signs during structured check-ins. Camera-based rPPG estimates heart rate, respiratory rate, and related signals from a short facial recording using a phone or tablet the patient already owns. It is best suited to post-discharge, chronic-care, and hospital-at-home monitoring rather than continuous acute telemetry.

How accurate is camera-based RPM compared to a device?

Published 2023 and 2024 studies report heart-rate accuracy around 97 percent and pulse-rate mean absolute error near 1 bpm under controlled conditions, with respiratory rate somewhat lower. Accuracy declines at very high heart rates and with heavy motion, so readings are best used as trend and triage signals with escalation pathways for confirmation.

Why does no-wearable monitoring improve adherence?

It removes the failure points specific to hardware: charging, pairing, lost equipment, and the cognitive load of an unfamiliar device. With nothing to wear or operate beyond opening an app, the only remaining adherence variable is the daily habit itself, which raises completion rates and produces denser trend data.

Is wearable-free RPM more equitable?

Often, yes. A 2024 study found wearable use in underserved communities at roughly 14 percent, while smartphone ownership is substantially higher. Building monitoring on devices patients already have removes a hardware supply barrier that disproportionately affects lower-income and rural populations.

Circadify is building toward this exact problem space: camera-based monitoring that patients actually complete because there is no device to abandon. If your team is weighing whether a wearable-free model could lift adherence and lower logistics cost across your panel, you can evaluate a no-wearable RPM pilot program and see how it fits your population.